Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Oct;84(20):7232–7236. doi: 10.1073/pnas.84.20.7232

Antigen-specific drug-targeting used to manipulate an immune response in vivo.

M M Abu-hadid 1, R B Bankert 1, G L Mayers 1
PMCID: PMC299265  PMID: 2444976

Abstract

The administration of dextran-conjugated cytosine arabinonucleoside (araC) to BALB/c mice at various times prior to but not subsequent to immunization with native dextran renders mice unresponsive to this thymic-independent antigen. These results demonstrate that the primary immune response to an antigen can be selectively and efficiently suppressed or eliminated in vivo by the delivery of a single dose of an appropriate antigen-cytotoxic drug conjugate. Evidence presented here indicates that the dextran-araC conjugate (toxogen) acts directly and selectively upon unprimed dextran-specific antibody-forming cell precursors, presumably by binding to their receptors and subsequent internalization of the resultant receptor-toxogen complexes. The resistance of antigen-primed mice to the cytotoxic effect of the toxogen could result from the failure of dextran-primed cells to reexpress antigen-specific receptors, from an alternative processing of the toxogen, or from the inability of the antigen-primed cells to internalize a second round of receptor-ligand complexes. We also determined that B cells responding to thymic-dependent antigens were not affected by the prior exposure to a toxogen. The inability to eliminate or suppress the primary response to a thymic-dependent antigen via the administration of a cytotoxic drug-antigen conjugate distinguishes the thymic-independent set of B cells from the thymic-dependent B-cell repertoire. The difference between these two B-cell compartments could be due either to differences in the amount of ligand bound to receptors or to differences in the trafficking patterns of receptor-ligand complexes within each cell type.

Full text

PDF
7232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnon R., Sela M. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies. Immunol Rev. 1982;62:5–27. doi: 10.1111/j.1600-065x.1982.tb00387.x. [DOI] [PubMed] [Google Scholar]
  2. Bankert R. B., Mayers G. L., Pressman D. Mechanisms of B cell tolerance. I. Tolerance to dextran B1355 induced with the oxidized dextran. J Immunol. 1977 Apr;118(4):1265–1270. [PubMed] [Google Scholar]
  3. Bankert R. B., Mazzaferro D., Mayers G. L. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen. Hybridoma. 1981;1(1):47–58. doi: 10.1089/hyb.1.1981.1.47. [DOI] [PubMed] [Google Scholar]
  4. Colly L. P., van Bekkum D. W., Hagenbeek A. Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia. Leuk Res. 1984;8(6):953–963. doi: 10.1016/0145-2126(84)90049-3. [DOI] [PubMed] [Google Scholar]
  5. Diener E., Diner U. E., Sinha A., Xie S., Vergidis R. Specific immunosuppression by immunotoxins containing daunomycin. Science. 1986 Jan 10;231(4734):148–150. doi: 10.1126/science.3484557. [DOI] [PubMed] [Google Scholar]
  6. Gordon R. O., Wade M. E., Mitchell M. S. The production of tolerance to human erythrocytes in the rat with cytosine arabinoside or cyclophosphamide. J Immunol. 1969 Aug;103(2):233–243. [PubMed] [Google Scholar]
  7. Goud B., Antoine J. C., Gonatas N. K., Stieber A., Avrameas S. A morphological and functional study on antigen binding and endocytosis by immunocytes. Immunology. 1980 Dec;41(4):833–848. [PMC free article] [PubMed] [Google Scholar]
  8. Howard J. G., Courtenay B. M. Influence of molecular structure on the tolerogenicity of bacterial dextrans. II. The alpha1--3-linked epitope of dextran B1355. Immunology. 1975 Oct;29(4):599–610. [PMC free article] [PubMed] [Google Scholar]
  9. Hurwitz E., Kashi R., Arnon R., Wilchek M., Sela M. The covalent linking of two nucleotide analogues to antibodies. J Med Chem. 1985 Jan;28(1):137–140. doi: 10.1021/jm00379a023. [DOI] [PubMed] [Google Scholar]
  10. Mayers G. L., Grossberg A. L., Pressman D. Arginine and lysine in binding sites of anti-4-azophthalate antibodies. Immunochemistry. 1973 Jan;10(1):37–41. doi: 10.1016/0019-2791(73)90248-6. [DOI] [PubMed] [Google Scholar]
  11. Mishell R. I., Dutton R. W. Immunization of dissociated spleen cell cultures from normal mice. J Exp Med. 1967 Sep 1;126(3):423–442. doi: 10.1084/jem.126.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pallavicini M. G. Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations. Pharmacol Ther. 1984;25(2):207–238. doi: 10.1016/0163-7258(84)90044-5. [DOI] [PubMed] [Google Scholar]
  13. SKOM J. H., TALMAGE D. W. The role of nonprecipitating insulin antibodies in diabetes. J Clin Invest. 1958 Jun;37(6):787–793. doi: 10.1172/JCI103665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schepart B. S., Mayers G. L., Bankert R. B. Failure of PFC inhibition assays to distinguish idiotypically between clonotypes that are readily distinguishable by RIA analysis. J Immunol. 1985 Sep;135(3):1683–1689. [PubMed] [Google Scholar]
  15. Valeriote F. Cellular aspects of the action of cytosine arabinoside. Med Pediatr Oncol. 1982;10 (Suppl 1):5–26. doi: 10.1002/mpo.2950100704. [DOI] [PubMed] [Google Scholar]
  16. Vitetta E. S., Uhr J. W. The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation. Transplantation. 1984 Jun;37(6):535–538. doi: 10.1097/00007890-198406000-00001. [DOI] [PubMed] [Google Scholar]
  17. Weigle W. O. Immunological unresponsiveness. Adv Immunol. 1973;16:61–122. doi: 10.1016/s0065-2776(08)60296-5. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES